Back
Aldeyra Therapeutics Stock Price Chart
Sponsored
ALDX
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
30
ALDX
Aldeyra Therapeutics
Last Price:
4.21
Seasonality Move:
5.49%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALDX is experiencing slight buying pressure.
Aldeyra Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.92 | Sell |
20-day SMA: | 5.22 | Sell |
50-day SMA: | 5.46 | Sell |
200-day SMA: | 4.29 | Sell |
8-day EMA: | 4.74 | Sell |
20-day EMA: | 5.08 | Sell |
50-day EMA: | 5.2 | Sell |
200-day EMA: | 4.75 | Sell |
Aldeyra Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 28.96 | Sell |
Chaikin Money Flow: | -517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.87 - 5.69) | Sell |
Bollinger Bands (100): | (3.98 - 5.8) | Sell |
Aldeyra Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aldeyra Therapeutics Stock
Is Aldeyra Therapeutics Stock a Buy?
- Aldeyra Therapeutics share price is 4.21 while ALDX 8-day simple moving average is 4.92, which is a Sell signal.
- The stock price of ALDX is 4.21 while Aldeyra Therapeutics 20-day SMA is 5.22, which makes it a Sell.
- Aldeyra Therapeutics 50-day simple moving average is 5.46 while ALDX share price is 4.21, making it a Sell technically.
- ALDX stock price is 4.21 and Aldeyra Therapeutics 200-day simple moving average is 4.29, creating a Sell signal.
ALDX Technical Analysis vs Fundamental Analysis
Sell
30
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy or a Sell?
-
Aldeyra Therapeutics stock is rated a Sell
The current Aldeyra Therapeutics [ALDX] share price is $4.21. The Score for ALDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Aldeyra Therapeutics Stock Info
Market Cap:
250.7M
Price in USD:
4.21
Share Volume:
621.08K
Aldeyra Therapeutics 52-Week Range
52-Week High:
6.55
52-Week Low:
2.43
Sell
30
Aldeyra Therapeutics (ALDX)
is a Sell
Aldeyra Therapeutics Share Price Forecast
-
What is the Aldeyra Therapeutics stock price today?
The Aldeyra Therapeutics stock price is 4.21 USD today. -
Will ALDX stock go up or go down?
Aldeyra Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aldeyra Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aldeyra Therapeutics is overvalued.
Is Aldeyra Therapeutics Stock a Buy?
- Aldeyra Therapeutics share price is 4.21 while ALDX 8-day exponential moving average is 4.74, which is a Sell signal.
- The stock price of ALDX is 4.21 while Aldeyra Therapeutics 20-day EMA is 5.08, which makes it a Sell.
- Aldeyra Therapeutics 50-day exponential moving average is 5.20 while ALDX share price is 4.21, making it a Sell technically.
- ALDX stock price is 4.21 and Aldeyra Therapeutics 200-day simple moving average is 4.75, creating a Sell signal.
Fundamental Analysis of Aldeyra Therapeutics
Is Aldeyra Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.14 per share.
Technical Analysis of Aldeyra Therapeutics
Should I short Aldeyra Therapeutics stock?
- ALDX Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Aldeyra Therapeutics is a Sell
- Aldeyra Therapeutics Relative Strength Index (RSI) is 28.96, which suggest Aldeyra Therapeutics is oversold
- The Bollinger Bands (25) for Aldeyra Therapeutics is (4.87 - 5.69), which suggest Aldeyra Therapeutics is a Sell
- The Bollinger Bands (100) for Aldeyra Therapeutics is (3.98 - 5.8), which suggest Aldeyra Therapeutics is a Sell
* Aldeyra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.